Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act

Compounding/Drug Safety

Source: FDA Center for Drug Evaluation and Research - What's New - April 21, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news